Paul Aisen, MD - Keck School of Medicine of USC
![](https://ca-times.brightspotcdn.com/dims4/default/6e747f9/2147483647/strip/false/crop/5670x3557+0+0/resize/1486x932!/quality/75/?url=https%3A%2F%2Fcalifornia-times-brightspot.s3.amazonaws.com%2F2e%2Ff5%2F62b75e45498e96570c9942d2b9ba%2F460837-sd-me-alzheimers-ec-003.jpg)
USC continues to build Alzheimer's program in San Diego after settling painful lawsuit with UC San Diego - The San Diego Union-Tribune
Faculty - Department of Medicine
Michael S. Rafii, MD, PhD - Keck School of Medicine of the University of Southern California
![](https://hscnews.usc.edu/wp-content/uploads/2016/02/Aisen-1-web.jpg)
Expert discusses progress in treating, preventing onset of Alzheimer's disease - HSC News
![](https://keck.usc.edu/news/wp-content/uploads/sites/68/2023/11/Pappas-Quad_clouds.jpg)
Keck School researchers among world's most influential resources
Keck School of Medicine of the University of Southern California on LinkedIn: ATRI Instrumental in FDA Approval of Lequembi (lecanemab)
![](https://today.usc.edu/wp-content/uploads/2024/02/libraries_GR7_3105-320x180.jpg)
USC's Paul Aisen, pioneering Alzheimer's researcher, honored with Epstein Alzheimer's Disease Director's Chair - USC Today
![](https://www.alzsd.org/wp-content/uploads/2023/05/2023-Date-with-a-Cure-Panel.png)
Meet the Researchers: Date with a Cure 2023 - Alzheimer's San Diego
Lyn Than, MS on LinkedIn: FDA Advisory Committee Votes Unanimously to Confirm the Clinical Benefit…